Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBITDA (2023 - 2025)

Historic EBITDA for ASP Isotopes (ASPI) over the last 3 years, with Q3 2025 value amounting to -$12.1 million.

  • ASP Isotopes' EBITDA fell 9948.13% to -$12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.5 million, marking a year-over-year decrease of 31246.93%. This contributed to the annual value of -$33.7 million for FY2024, which is 9240.61% down from last year.
  • ASP Isotopes' EBITDA amounted to -$12.1 million in Q3 2025, which was down 9948.13% from -$74.1 million recorded in Q2 2025.
  • ASP Isotopes' EBITDA's 5-year high stood at -$3.8 million during Q4 2023, with a 5-year trough of -$74.1 million in Q2 2025.
  • Its 3-year average for EBITDA is -$13.2 million, with a median of -$7.3 million in 2025.
  • The largest annual percentage gain for ASP Isotopes' EBITDA in the last 5 years was 290.12% (2025), contrasted with its biggest fall of 80737.96% (2025).
  • ASP Isotopes' EBITDA (Quarter) stood at -$3.8 million in 2023, then crashed by 211.95% to -$12.0 million in 2024, then dropped by 1.09% to -$12.1 million in 2025.
  • Its EBITDA was -$12.1 million in Q3 2025, compared to -$74.1 million in Q2 2025 and -$7.3 million in Q1 2025.